INNATE PHARMA: ifrs:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities
| Value | {"amount": -3998000.0} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:19:24.905918+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/a5fa700c-1b8d-4c1e-becd-af02557201a4
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2024-12-31Retrieved: 2026-08-23T23:19:24.905918+02:00
Raw response sha256:
c477e47ed4a27d7e67bbe48f2d843a4d…Cite as: FACTANKER, https://factanker.com/fact/a5fa700c-1b8d-4c1e-becd-af02557201a4
History
- no predecessors — first report